IRIS Accounts Production v24.2.0.383 07883688 director 1.1.24 31.12.24 31.12.24 0 0 false true false false true false Ordinary shares 1.00000 Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078836882023-12-31078836882024-12-31078836882024-01-012024-12-31078836882022-12-31078836882023-01-012023-12-31078836882023-12-3107883688ns15:EnglandWales2024-01-012024-12-3107883688ns14:PoundSterling2024-01-012024-12-3107883688ns10:Director12024-01-012024-12-3107883688ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3107883688ns10:SmallEntities2024-01-012024-12-3107883688ns10:AuditExemptWithAccountantsReport2024-01-012024-12-3107883688ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3107883688ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107883688ns10:FullAccounts2024-01-012024-12-3107883688ns10:OrdinaryShareClass12024-01-012024-12-3107883688ns10:RegisteredOffice2024-01-012024-12-3107883688ns5:CurrentFinancialInstruments2024-12-3107883688ns5:CurrentFinancialInstruments2023-12-3107883688ns5:ShareCapital2024-12-3107883688ns5:ShareCapital2023-12-3107883688ns5:RetainedEarningsAccumulatedLosses2024-12-3107883688ns5:RetainedEarningsAccumulatedLosses2023-12-3107883688ns5:PlantMachinery2024-01-012024-12-3107883688ns5:ComputerEquipment2023-12-3107883688ns5:ComputerEquipment2024-01-012024-12-3107883688ns5:ComputerEquipment2024-12-3107883688ns5:ComputerEquipment2023-12-3107883688ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 07883688 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

PAUL RICHMAN PATHOLOGY LTD

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 6

PAUL RICHMAN PATHOLOGY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTOR: P Richman





REGISTERED OFFICE: Ferrari House
258 Field End Road
Eastcote
Middlesex
HA4 9UU





REGISTERED NUMBER: 07883688 (England and Wales)





ACCOUNTANTS: Diverset Limited
Chartered Accountants
Ferrari House
258 Field End Road
Ruislip
Middlesex
HA4 9UU

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,200 2,750

CURRENT ASSETS
Cash at bank 744,579 739,039

CREDITORS
Amounts falling due within one year 5 5,631 12,268
NET CURRENT ASSETS 738,948 726,771
TOTAL ASSETS LESS CURRENT LIABILITIES 741,148 729,521

PROVISIONS FOR LIABILITIES 550 523
NET ASSETS 740,598 728,998

CAPITAL AND RESERVES
Called up share capital 6 1 1
Retained earnings 740,597 728,997
SHAREHOLDERS' FUNDS 740,598 728,998

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 February 2025 and were signed by:





P Richman - Director


PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

Paul Richman Pathology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2024
and 31 December 2024 4,948
DEPRECIATION
At 1 January 2024 2,198
Charge for year 550
At 31 December 2024 2,748
NET BOOK VALUE
At 31 December 2024 2,200
At 31 December 2023 2,750

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 2,792 10,087
Other creditors 2,839 2,181
5,631 12,268

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary shares £1 1 1

7. CONTROLLING PARTY

The controlling party is P Richman.

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
PAUL RICHMAN PATHOLOGY LTD


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Paul Richman Pathology Ltd for the year ended 31 December 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Paul Richman Pathology Ltd in accordance with the terms of our engagement letter dated 21 June 2014. Our work has been undertaken solely to prepare for your approval the financial statements of Paul Richman Pathology Ltd and state those matters that we have agreed to state to the director of Paul Richman Pathology Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Paul Richman Pathology Ltd and its director for our work or for this report.

It is your duty to ensure that Paul Richman Pathology Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Paul Richman Pathology Ltd. You consider that Paul Richman Pathology Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Paul Richman Pathology Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Diverset Limited
Chartered Accountants
Ferrari House
258 Field End Road
Ruislip
Middlesex
HA4 9UU


10 February 2025